← Back to Search

Diagnostic Device

HIV Self-Test for HIV (OQHIVST Trial)

N/A
Recruiting
Led By Sean B Rourke, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 - 12 months
Awards & highlights

OQHIVST Trial Summary

This trial is testing a new method of at-home HIV testing using oral fluid. They want to see if it is accurate and easy to use.

Eligible Conditions
  • HIV Testing
  • Human Immunodeficiency Virus Infection

OQHIVST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 - 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 - 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Device Performance
Label Comprehension
Readability or Interpretation
+1 more
Secondary outcome measures
Secondary efficacy analysis

OQHIVST Trial Design

1Treatment groups
Experimental Treatment
Group I: Investigational DeviceExperimental Treatment1 Intervention
Observed self-test of oral fluid with the OraQuick HIV Self-Test
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OraQuick® HIV Self-Test
2018
N/A
~7880

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
537 Previous Clinical Trials
446,639 Total Patients Enrolled
1 Trials studying HIV Testing
600 Patients Enrolled for HIV Testing
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,451,813 Total Patients Enrolled
1 Trials studying HIV Testing
600 Patients Enrolled for HIV Testing
Sean B Rourke, PhDPrincipal InvestigatorMAP Centre for Urban Health Solutions, St. Micheal's Hospital
2 Previous Clinical Trials
5,600 Total Patients Enrolled
1 Trials studying HIV Testing
600 Patients Enrolled for HIV Testing

Media Library

OraQuick® HIV Self-Test (Diagnostic Device) Clinical Trial Eligibility Overview. Trial Name: NCT05020353 — N/A
HIV Testing Research Study Groups: Investigational Device
HIV Testing Clinical Trial 2023: OraQuick® HIV Self-Test Highlights & Side Effects. Trial Name: NCT05020353 — N/A
OraQuick® HIV Self-Test (Diagnostic Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05020353 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide me with a count of the number of Canadian medical sites currently conducting this research?

"The current clinical trial is active at 5 different medical centres, including Clinique médicale l'Actuel in Montreal, Hassle Free Clinic in Ottawa, and ByWard Family Health Team in Vancouver. An additional five sites are also participating."

Answered by AI

How many participants are being welcomed into this experiment?

"Affirmative, the information hosted on clinicaltrials.gov discloses that this medical trial is currently looking for participants. It was initially posted on June 21st 2022 and underwent its last modification two days later. This research project needs to recruit 900 individuals at 5 different sites to meet its quotas."

Answered by AI

Are participants being sought for this research endeavor at the present time?

"According to the clinicaltrials.gov webpage, this experiment is currently recruiting volunteers. The trial was made public on June 21st 2022 and edited for a second time two days later."

Answered by AI

Who else is applying?

What state do they live in?
British Columbia
California
How old are they?
18 - 65
What site did they apply to?
Cool Aid Community Health Centre
Hassle Free Clinic
What portion of applicants met pre-screening criteria?
Met criteria
~327 spots leftby Apr 2025